Aquaporin-1 Autoantibodies in Patients with Neuromyelitis Optica Spectrum Disorders (S60.004)
John S. Tzartos, Christos L. Stergiou, Konstantinos Kilidireas, Paraskevi Zisimopoulou, Thomas V. Thomaidis, Socrates J. Tzartos
Abstract
John S. Tzartos, Christos L. Stergiou, Konstantinos Kilidireas, Paraskevi Zisimopoulou, Thomas V. Thomaidis, Socrates J. Tzartos
Abstract
OBJECTIVE: To investigate whether patients with neuromyelitis optica (NMO) spectrum disorders (NMOsd) seronegative for autoantibodies to aquaporin-4 (AQP4), a water-channel expressed in human CNS astrocytes, have autoantibodies to aquaporin-1(AQP1).
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE: To investigate whether patients with neuromyelitis optica (NMO) spectrum disorders (NMOsd) seronegative for autoantibodies to aquaporin-4 (AQP4), a water-channel expressed in human CNS astrocytes, have autoantibodies to aquaporin-1(AQP1).
Key concepts: Neuromyelitis optica, Aquaporin 4, Autoantibody, Medicine, Spectrum disorder, Immunology, Internal medicine, Antibody